Biggest News Aggregation in the World
📰 Approval Program News

Page 53 - Approval Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Approval Program. Real-time updates on events, politics, business and more.

European Commission Approves Pfizer's ELREXFIO for Relapsed and Refractory Multiple Myeloma

08.12.2023 - Pfizer Inc. (NYSE:PFE) today announced the European Commission (EC) has granted conditional marketing authorization for ELREXFIO (elranatamab). ELREFXIO is a targeted immunotherapy for the treatment of adult patients with relapsed and refractory ...
United Kingdom Al Hamed Exchange Commission Approval Program Drug Administration European Commission

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science